| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.4M | -2.4% |
| Cost of Revenue | $16.4M | +5.2% |
| Gross Profit | $4.0M | -24.6% |
| R&D Expense | $13K | +578.8% |
| SG&A Expense | $22.4M | -40.6% |
| Operating Income | -$33.2M | +13.5% |
| Pre-tax Income | -$35.3M | +7.8% |
| Income Tax | $230K | +139.6% |
| Net Income | -$35.0M | +9.9% |
| EPS (Basic) | -$0.05 | +0.0% |
| EPS (Diluted) | -$0.05 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -59.8% |
| Current Assets | $11.0M | -33.5% |
| Total Assets | $26.9M | -16.0% |
| Current Liabilities | $12.3M | +25.4% |
| Long-term Debt | $0 | — |
| Total Liabilities | $122.5M | +29.0% |
| Stockholders' Equity | -$94.9M | -54.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.3M | +68.7% |
| Capital Expenditures | $3K | — |
| Investing Cash Flow | -$333K | — |
| Financing Cash Flow | $4.7M | -84.9% |
| Free Cash Flow | -$8.3M | — |